Carbimazole is an orally active antithyroid agent that rapidly converts to Methimazole after absorption. It prevents the thyroid peroxidase enzyme from iodinating and coupling tyrosine residues on thyroglobulin, thereby reducing the production of thyroxine. Carbimazole also exhibits anti-inflammatory and neuronal-protective activities, suggesting its use for hyperthyroidism and neurological research.
- Orally active antithyroid agent
- Converts to methimazole after absorption
- Reduces thyroxine production
- Exhibits anti-inflammatory activities
- Exhibits neuronal-protective activities